European Pharmaceutical Review

JANUARY 13, 2025

Chiesi began with a 350 million investment to deliver carbon-minimal inhalers for asthma and chronic obstructive pulmonary disease (COPD) patients. The effect of medicines on patients must remain paramount, but we should not have to choose between their health and the health of the planet. Pulmonary Pharmacology & Therapeutics.

Medicine 52

Medicine Pharmaceutical Manufacturing Government 52

MedCity News

JUNE 16, 2023

Investors in 2022 appeared confident that the continued transformation of drug research and development protocols and the overall life sciences industry will not only include digital health solutions, but will even depend on them for data collection, analysis, patient engagement, and even their therapeutic properties.

Pharma 311

Pharma Food and Drug Administration Recruitment Patients 311

European Pharmaceutical Review

MAY 2, 2023

3 With greater scientific understanding of cancer, the industry has made significant progress in developing innovative medicines to help patients. However, access to these medicines is not close to meeting patient demand, creating inequalities in the health prospects of those diagnosed with cancer. 1,2 In the EU, an estimated 2.7

Patients 105

Patients Medicine Marketing Medical 105

European Pharmaceutical Review

FEBRUARY 27, 2024

While she is stepping down from her current role, Dame June shared that she still hopes to contribute] “to patient safety and public health in other ways” “It has been an enormous privilege to have led the MHRA through a time of change which is unprecedented in UK medical products regulation.

Safety 111

Safety Pharmacology Medicine Management 111

Pharmaceutical Technology

OCTOBER 10, 2022

The company is aiming to enrol the first patient in the ALETTA Phase III trial in Q1 or Q2 of 2023, says Dr. Jan van der Mooren, Freya’s chief medical officer (CMO). In 2019, the agency authorized the use of Vyleesi, an injectable form of bremelanotide, for the same condition. There are no approved treatments in the EU.

Pharmacology 59

Pharmacology Side effects FDA Safety 59

European Pharmaceutical Review

MARCH 11, 2024

3 While gone are the days when an HIV diagnosis necessitated taking so many pills that patients had to set multiple alarm clocks, self-stigma and concerns of external stigma still exist. About the author Sherene Min, MD, MPH, is Vice President of Global Clinical Development at ViiV Healthcare , a role she assumed in October 2019.

Medicine 98

Medicine Pharmacology Leads Healthcare 98

pharmaphorum

JANUARY 12, 2023

The Attorney General of Alabama has threatened to use an obscure law passed in 2006 to prosecute women who terminate a pregnancy using pharmacological means, shortly after the FDA made access to the drugs easier.

Pharmacology 52

Pharmacology Retail Healthcare Provider FDA 52

European Pharmaceutical Review

SEPTEMBER 22, 2023

Targeting toxic species of Abeta, such as multimers (with aducanumab and lecanemab) or pyroglutamate Abeta3-42 (with donanemab), induced significant removal of Abeta plaque load in the brains of Alzheimer’s patients, leading to the delay in cognitive decline. Treatment with the mAbs delayed cognitive decline by 2.6 months for lecanemab and 5.5

Food and Drug Administration 97

Food and Drug Administration Safety Patients Leads 97

Pharmaceutical Technology

NOVEMBER 3, 2022

Cardiovascular medicines were ranked as the sixth most affected drug class by shortages, as per a 2019 European Association of Hospital Pharmacists (EAHP) survey, says the organisation’s director of finance, Nenad Miljkovi?. And patients can die when we do not have these readily available,” he says. Critical care especially hit.

Medicine 111

Medicine Manufacturing Pharmacology Leads 111

Pharmaceutical Technology

DECEMBER 16, 2022

This year saw great progress towards making new therapeutics for malaria available sooner rather than later, says Karen Barnes, PhD, professor at the University of Cape Town’s Division of Clinical Pharmacology. As per the WHO’s 2022 malaria report , 63,000 malaria deaths were attributed to Covid-19-caused disruptions to services from 2019–21.

Pharmacology 105

Pharmacology Pharma Pharmaceutical Manufacturing 105